Aspen Aerogels, Inc. (ASPN) is a publicly traded Industrials sector company. As of May 21, 2026, ASPN trades at $5.09 with a market cap of $441.74M and a P/E ratio of -3.71. ASPN moved +0.89% today. Year to date, ASPN is +57.41%; over the trailing twelve months it is -19.68%. Its 52-week range spans $2.30 to $30.24. Analyst consensus is buy with an average price target of $5.55. Rallies surfaces ASPN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aspen Aerogels Starts Phased Restart of East Providence Plant After April 8 Incident: Aspen Aerogels has initiated a staged restart of its East Providence, Rhode Island manufacturing facility following an April 8 incident, completing mechanical, safety and operational inspections. The company will execute a phased ramp-up of production and expects a gradual return to full operational capacity over time.
| Metric | Value |
|---|---|
| Price | $5.09 |
| Market Cap | $441.74M |
| P/E Ratio | -3.71 |
| EPS | $-1.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.24 |
| 52-Week Low | $2.30 |
| Volume | 725 |
| Avg Volume | 0 |
| Revenue (TTM) | $230.26M |
| Net Income | $-111.99M |
| Gross Margin | 11.93% |
5 analysts cover ASPN: 0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.55.